Aether is building the post-scarcity future by developing the most advanced enzyme engineering platform to date. By treating protein engineering as a search problem, we are pushing the boundaries of what’s possible in biocatalysis, and revolutionizing the way molecules are made.
We’ve built proprietary robotics and state-of-the-art deep learning algorithms to drive massively parallelized experimentation, enabling us to search through trillions of enzyme designs and find a viable match for almost any chemical process. Aether’s technology integrates into existing production pipelines, dramatically reduces manufacturing costs, is sustainable, and minimizes time to market for new products.
We’ve built proprietary robotics and state-of-the-art deep learning algorithms to drive massively parallelized experimentation, enabling us to search through trillions of enzyme designs and find a viable match for almost any chemical process. Aether’s technology integrates into existing production pipelines, dramatically reduces manufacturing costs, is sustainable, and minimizes time to market for new products.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
anti-viral precursor
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
3
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
